Queens Hospital Center, also known as NYC Health + Hospitals/Queens and originally called Queens General Hospital, is a large public hospital campus in the Jamaica Hills and Hillcrest neighborhoods of Queens in New York City. It is operated by NYC Health + Hospitals, a public benefit corporation of the city.

During the past decade, Queens Hospital Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 22 clinical trials were completed, i.e. on average, 183.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 13 clinical trials were completed. i.e. 216.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queens Hospital Center" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Memorial Sloan Kettering Cancer Center" with 4 trials sponsored, "GOG Foundation" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queens Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Queens Hospital Center" are "Breast Cancer" (7 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Mucinous Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials) and "Ovarian Endometrioid Adenocarcinoma" (5 trials). Many other conditions were trialed in "Queens Hospital Center" in a lesser frequency.

Most popular intervention types in "Queens Hospital Center" are "Drug" (34 trials), "Other" (24 trials), "Biological" (13 trials), "Behavioral" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (11 trials), "Bevacizumab" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Queens Hospital Center" are 28 trials for "All" genders, 18 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Queens Hospital Center". undefined are not yet recruiting, 4 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Queens Hospital Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Queens Hospital Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Queens Hospital Center has several departments that took part in Clinical trials: "Queens Cancer Center of Queens Hospital" - 58 trials, "Queens Hospital Cancer Center" - 2 trials